# Aegerion Pharmaceuticals, Inc.: Form D filings

Aegerion Pharmaceuticals, Inc., a pharmaceuticals company in Bridgewater, NJ, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on June 28, 2010, reports $18.3 million sold of a $19.8 million offering to 20 investors.

Find out what Aegerion Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Aegerion%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Aegerion%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Faegerion-pharmaceuticals-inc-1338042)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Aegerion%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Aegerion%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Faegerion-pharmaceuticals-inc-1338042)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1140 ROUTE 22 EAST, SUITE 304, Bridgewater, NJ, 08807
- Phone: (908) 704-1300
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2005
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1338042

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 28, 2010 | Amendment | $19,814,760 | $18,314,760 | $1,500,000 | 20 | Sep 2, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1338042/000133804210000002/0001338042-10-000002-index.htm) |
| Feb 9, 2010 | Amendment | $16,814,760 | $16,814,760 | $0 | 20 | Sep 2, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1338042/000133804210000001/0001338042-10-000001-index.htm) |
| Jul 15, 2009 | Amendment | $15,814,760 | $13,562,101 | $2,252,659 | 20 | Sep 2, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1338042/000133804209000003/0001338042-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David H. Scheer | Director |  |
| Alison M. Kiley | Director |  |
| Jason H. Fisherman | Director |  |
| Peter M. Garrambone | Director |  |
| William H. Lewis | Executive Officer |  |
| Michele M. Ollier | Director |  |
| Christine H. Pellizzari | Executive Officer |  |
| Antonio M. Gotto | Director |  |
| William H. Sasiela | Executive Officer |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Jun 28, 2010](https://specstream.ai/data/form-d/week/2010-06-28) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Aegerion Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).